Article

Use of the levonorgestrel-IUD in the treatment of menorrhagia: improving patient outcomes while reducing the need for surgical management.

Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville, Florida, USA.
Managed care interface 04/2007; 20(3):47-50. pp.47-50
Source: PubMed

ABSTRACT Menorrhagia impairs the quality of life and often leads to hysterectomy. Although hysterectomy provides definitive management of menorrhagia, the procedure is associated with morbidity, permanent sterility, and high cost. Alternative treatments, including pharmaceuticals, intrauterine devices, and other minor surgical procedures are less invasive and less expensive. In particular, the levonorgestrel-releasing intrauterine system (LNG-IUS), a nonsurgical, reversible treatment, provides effective management for many women with menorrhagia while minimizing morbidity and health care costs.

0 0
 · 
0 Bookmarks
 · 
16 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

Alternative treatments
 
definitive management
 
health care costs
 
intrauterine devices
 
invasive
 
levonorgestrel-releasing intrauterine system
 
menorrhagia
 
minor surgical procedures
 
nonsurgical
 
women